-+ 0.00%
-+ 0.00%
-+ 0.00%

ARROWHEAD PHARMACEUTICALS - TO FILE SUPPLEMENTAL NDA FOR PLOZASIRAN WITH U.S. FDA BEFORE END OF 2026

Reuters·07/22/2026 11:30:00

Please log in to view news